Flora Fertility this month closed a seed round to help fuel the company’s mission to expand access to reproductive care across North America.
The Calgary-born fertility insurance platform raised US$5 million from a long list of investors including ManchesterStory, Slauson & Co., TruStage Ventures, BDC Capital, Marathon Fund, Adara Venture Capital, and undisclosed angels.
The round builds on pre-seed funding secured in 2024 from Highline Beta and others.
Fertility is “one of the largest uninsured financial risks people face,” suggests Laura McDonald, cofounder of Flora, “yet the system today only offers support once you’re already in crisis—and often only if your employer provides it.”
The Alberta innovator’s tech stack combines proprietary advanced underwriting, individualized risk modelling, AI, and omni-channel distribution to make fertility coverage affordable, personalized, and accessible earlier.
“We’re creating a new category where fertility becomes something you can proactively plan for, not just pay for when it’s too late,” says McDonald.
The funding will support Flora as the company drives category creation in private fertility insurance, a new and untapped market, according to Nicole Gunderson, Partner at ManchesterStory.
“Flora is building something that has never existed before,” says Gunderson, describing the product as “affordable, portable fertility insurance that meets the next generation of women exactly where they are.”
Fertility costs “are one of the most significant—and overlooked—financial burdens women face,” notes Elizabeth McCluskey, Managing Director of TruStage Ventures. “With 72% of Gen Z women experiencing fertility anxiety, Flora can give an entire generation peace of mind.”
“The InsurTech opportunity here is enormous,” Gunderson believes, “and the Flora team has the expertise, technology, and vision to define this category.”
Flora is “removing a structural barrier that has kept fertility care out of reach for millions of women,” adds Miki Reynolds, Head of Programs at Slauson & Co., “and they’re doing it in a way that’s both financially innovative and deeply human.”
Fertility has long been considered “unpredictable and uninsurable, but the data tells a different story,” according to Dr. Christy Lane, cofounder of Flora.
“The earlier someone can access that coverage, the better their outcomes and the lower their costs,” explains Lane, “which is what makes this model so powerful.”
“We’re turning fertility from a reactive medical expense into a proactive, data-driven financial decision,” she stated.
Leave a Reply